Your browser doesn't support javascript.
loading
Molecular and clinical spectra of FBXL4 deficiency.
El-Hattab, Ayman W; Dai, Hongzheng; Almannai, Mohammed; Wang, Julia; Faqeih, Eissa A; Al Asmari, Ali; Saleh, Mohammed A M; Elamin, Mohammed A O; Alfadhel, Majid; Alkuraya, Fowzan S; Hashem, Mais; Aldosary, Mazhor S; Almass, Rawan; Almutairi, Faten B; Alsagob, Maysoon; Al-Owain, Mohammed; Al-Sharfa, Shirin; Al-Hassnan, Zuhair N; Rahbeeni, Zuhair; Al-Muhaizea, Mohammed A; Makhseed, Nawal; Foskett, Gretchen K; Stevenson, David A; Gomez-Ospina, Natalia; Lee, Chung; Boles, Richard G; Schrier Vergano, Samantha A; Wortmann, Saskia B; Sperl, Wolfgang; Opladen, Thomas; Hoffmann, Georg F; Hempel, Maja; Prokisch, Holger; Alhaddad, Bader; Mayr, Johannes A; Chan, Wenyaw; Kaya, Namik; Wong, Lee-Jun C.
Afiliação
  • El-Hattab AW; Division of Clinical Genetics and Metabolic Disorders, Pediatric Department, Tawam Hospital, Al-Ain, United Arab Emirates.
  • Dai H; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
  • Almannai M; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
  • Wang J; Medical Scientist Training Program and Program in Developmental Biology, Baylor College of Medicine, Houston, Texas.
  • Faqeih EA; Section of Medical Genetics, Children's Hospital, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Al Asmari A; Section of Medical Genetics, Children's Hospital, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Saleh MAM; Section of Medical Genetics, Children's Hospital, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Elamin MAO; Section of Medical Genetics, Children's Hospital, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Alfadhel M; King Abdullah International Medical Research Centre, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
  • Alkuraya FS; Division of Genetics, Department of Pediatrics, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs (NGHA), Riyadh, Saudi Arabia.
  • Hashem M; Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Aldosary MS; Department of Anatomy and Cell Biology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
  • Almass R; Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Almutairi FB; Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Alsagob M; Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Al-Owain M; Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Al-Sharfa S; Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
  • Al-Hassnan ZN; Department of Medical Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Rahbeeni Z; Department of Medical Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Al-Muhaizea MA; Department of Medical Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Makhseed N; Department of Medical Genetics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Foskett GK; Department of Anatomy and Cell Biology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
  • Stevenson DA; Department of Neurosciences, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Gomez-Ospina N; Department of Pediatrics, Al-Jahra Hospital, Ministry of Health, Al-Jahra City, Kuwait.
  • Lee C; Department of Pediatrics, Stanford University School of Medicine, Stanford, California.
  • Boles RG; Department of Pediatrics, Stanford University School of Medicine, Stanford, California.
  • Schrier Vergano SA; Department of Pediatrics, Stanford University School of Medicine, Stanford, California.
  • Wortmann SB; Department of Pediatrics, Stanford University School of Medicine, Stanford, California.
  • Sperl W; Lineagen, Salt Lake City, Utah.
  • Opladen T; Division of Medical Genetics and Metabolism, Children's Hospital of The King's Daughters, Norfolk, Virginia.
  • Hoffmann GF; Department of Pediatrics, Salzburger Landeskliniken, Paracelsus Medical University, Salzburg, Austria.
  • Hempel M; Institute of Human Genetics, Technische Universität München, Munich, Germany.
  • Prokisch H; Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
  • Alhaddad B; Department of Pediatrics, Salzburger Landeskliniken, Paracelsus Medical University, Salzburg, Austria.
  • Mayr JA; Centre for Child and Adolescent Medicine, Divisions of General Pediatrics, Neuropediatrics, and Metabolic Medicine, University Hospital, Heidelberg, Germany.
  • Chan W; Centre for Child and Adolescent Medicine, Divisions of General Pediatrics, Neuropediatrics, and Metabolic Medicine, University Hospital, Heidelberg, Germany.
  • Kaya N; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Wong LC; Institute of Human Genetics, Technische Universität München, Munich, Germany.
Hum Mutat ; 38(12): 1649-1659, 2017 12.
Article em En | MEDLINE | ID: mdl-28940506
ABSTRACT
F-box and leucine-rich repeat protein 4 (FBXL4) is a mitochondrial protein whose exact function is not yet known. However, cellular studies have suggested that it plays significant roles in mitochondrial bioenergetics, mitochondrial DNA (mtDNA) maintenance, and mitochondrial dynamics. Biallelic pathogenic variants in FBXL4 are associated with an encephalopathic mtDNA maintenance defect syndrome that is a multisystem disease characterized by lactic acidemia, developmental delay, and hypotonia. Other features are feeding difficulties, growth failure, microcephaly, hyperammonemia, seizures, hypertrophic cardiomyopathy, elevated liver transaminases, recurrent infections, variable distinctive facial features, white matter abnormalities and cerebral atrophy found in neuroimaging, combined deficiencies of multiple electron transport complexes, and mtDNA depletion. Since its initial description in 2013, 36 different pathogenic variants in FBXL4 were reported in 50 affected individuals. In this report, we present 37 additional affected individuals and 11 previously unreported pathogenic variants. We summarize the clinical features of all 87 individuals with FBXL4-related mtDNA maintenance defect, review FBXL4 structure and function, map the 47 pathogenic variants onto the gene structure to assess the variants distribution, and investigate the genotype-phenotype correlation. Finally, we provide future directions to understand the disease mechanism and identify treatment strategies.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA Mitocondrial / Encefalomiopatias Mitocondriais / Ubiquitina-Proteína Ligases / Proteínas F-Box / Estudos de Associação Genética Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Hum Mutat Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: DNA Mitocondrial / Encefalomiopatias Mitocondriais / Ubiquitina-Proteína Ligases / Proteínas F-Box / Estudos de Associação Genética Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Hum Mutat Ano de publicação: 2017 Tipo de documento: Article